State Board of Administration of Florida Retirement System
PLX icon

State Board of Administration of Florida Retirement System’s Protalix BioTherapeutics PLX Stock Holding History

State Board of Administration of Florida Retirement System’s Portfolio PLX Stock Details PLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-17,228
Closed -$30.7K – 2383
2023
Q4 		$30.7K Buy
+17,228
New +$26.8K ﹤0.01% 2377

Other funds holding PLX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

State Board of Administration of Florida Retirement System's PLX Position: Q1 2024 in Review

State Board of Administration of Florida Retirement System sold out of Protalix BioTherapeutics (PLX) in Q1 2024, closing a stake of 17,228 shares — an estimated $30.7K sold.

State Board of Administration of Florida Retirement System first reported a position in PLX in Q4 2023 and held it in 1 quarter. The position peaked at $30.7K in Q4 2023. 63 funds tracked by Wall St. Rank hold PLX as of Q1 2024.

  • State Board of Administration of Florida Retirement System reported no remaining Protalix BioTherapeutics position as of Q1 2024 after selling out during the quarter.
  • State Board of Administration of Florida Retirement System sold 17,228 Protalix BioTherapeutics shares in Q1 2024, an estimated $30.7K.
  • State Board of Administration of Florida Retirement System first reported a position in Protalix BioTherapeutics in Q4 2023 and held it in 1 quarter.
  • State Board of Administration of Florida Retirement System's Protalix BioTherapeutics position peaked at $30.7K in Q4 2023.
  • 63 funds tracked by Wall St. Rank held Protalix BioTherapeutics as of Q1 2024.

Based on State Board of Administration of Florida Retirement System's 13F filing for Q1 2024, filed 8 May 2024.